Warning: There are an increasing number of fraudulent websites that impersonate ECCMID. We would like to alert all our members and delegates to possible scams and we strongly advise you to use only the official ECCMID online registration for your bookings.

Abstract Guidelines

Regular abstract submission: 16 October - 29 November 2023, 16:00 CET


Submission of an abstract for ECCMID 2024 indicates your consent for the abstract to be available within the congress literature (electronic and in print). The submitted abstract should be based on novel data previously not presented or published. The ECCMID Programme Committee reserves the right to reject the presentation of abstract material at ECCMID 2024 if the same data have been published in an international journal earlier than six weeks before the congress.

Suppose the abstract has been submitted for publication, accepted, and published in a scientific journal between ECCMID abstract submission and the congress. In that case, we expect authors to ensure that data presented during the congress is updated or explores new perspectives to avoid redundancies and duplications of already published information.

NOTE: This rule does not apply to posted pre-prints.

Abstract quick start guide

Before submitting the abstract to ECCMID 2024, please read the guide explaining step-by-step how to navigate the submission process. If you do not find the answer to your specific question regarding submission, please contact us at eccmidabstracts[at]escmid.org.

Abstract type

Abstracts should fall into one of four selectable categories:


  1. Regular abstract
  2. Case report/series
  3. CGR cases


If ‘Case report/ series’ or ’CGR cases’ is selected, the template sections:

Background/Materials/Results/Conclusions will be automatically replaced by:

Background/Case(s) description/Discussion



If the submitter is a co-author of the abstract, we kindly ask you to include his/her information on the co-author list.

Please check the correct spelling and formatting of the author(s) names and affiliation(s).

Please use appropriate capitalisation and punctuation.

ESCMID takes no responsibility for errors in either author or affiliation information.



ALL CAPS for text (other than abbreviations or acronyms) are not allowed. The abstract text cannot be longer than 350 words.



The abstract title should be concise and submitted in line with scientific rules. This applies to special characters and words that must be CAPITALISED or italicised.


  • Please DO NOT capitalise the title except the first word
  • Please DO NOT use a dot to finish the title
  • Please DO NOT use any brand names in the title


ESCMID reserves the right to proof and adjust titles according to ESCMID guidelines format without the consent of the author.


Abstract body

Use the provided fields to draft your abstract. The text of the entire abstract must not exceed 350 words (excluding title and figure descriptions). Please ensure that different sections of your abstract are entered into the appropriate textbox. For research abstracts, briefly state the background, context of research, and its goals.


The methods section should provide the minimum required information on the research setting, data collection, and analytical methods.


The results presented in the abstract should be original, not published or presented previously.


For Case report/series and CGR cases (usually featuring a single instructive case or a series of up to 10 cases), emphasise the unique aspects of the case and discuss the learning points emerging from the case(s).


Reviews only or abstracts without data content cannot be accepted.



Please use the figure upload fields at the bottom to select up to three images. Figure sections can be used to upload images, graphs, or tables.


Accepted formats: JPEG or PNG. Size: 1000x1000 pixels max. File size: up to 5 MB. Images larger than the provided dimensions will be automatically resized to an A4 format in your submission confirmation.


Please check the readability of uploaded materials before submitting your abstract.


Spelling guidelines

Use British English spelling throughout. The International System of Units (SI) should be used wherever appropriate. Genus and species names should be written in full as mentioned first and abbreviated subsequently.


The following scientific rules apply (examples in brackets):


  • Systematic names (genus, family, and higher orders): capitalised (e.g., Chlamydia, Enterobacterales Picornaviridae)
  • Non-English expressions in English texts are written in italics (e.g., in vitro/in vivoad hocex officio)
  • Taxonomic names must be italicised (e.g., Staphylococcus aureusClostridium difficile)
  • Non-systematic names (e.g., plural): lowercase and not italicised (group A streptococci, mycobacteria)
  • Generic drug names: lowercase (e.g., penicillin)
  • Do not use brand names in titles: product names are allowed in the abstract text, but must be avoided in the title
  • Please follow standard English grammar rules, including a space after full stops and commas
  • Only common abbreviations may be used without definition

Abstract topics

The full list of abstract topics may be found here.


Please choose the best-fitting abstract category and sub-category to ensure a sound and fair review by the most suitable reviewing experts. 


All case and case series abstracts will be automatically assigned to category 12. Case reports and case series (n<10).



Authors are asked to choose two keywords to define the best abstract content.


Submit your abstract

You can save your abstract at any time. Please make sure to fill all fields correctly before final submission. Changes in the abstract are not possible after submission. After submission, an email confirmation will be sent to the submitter (please state your correct email address!). All co-authors will be notified by email and receive a copy of the submitted abstract. The submitter is responsible for obtaining permission for submission and presentation of the abstract from all co-authors and any relevant stakeholders. All correspondence regarding acceptance or rejection, including further information on the mode of presentation, etc., will be sent to the presenting author.


If an abstract is rejected as an oral presentation, it is possibility to be accepted as a poster, and the presenting authors will be informed via e-mail.


Should you decide to change the type of abstract once you have started the submission, please withdraw your current abstract and re-start the submission process with new content.



Please ensure that all author names are correct upon submission. It is the responsibility of the presenting author to ensure that this is kept up to date in case of changes. Following ECCMID, a certificate of presentation will be available to the presenting authors at cme.eccmid.org. The presenting author is then responsible for disseminating this certificate to co-authors.


If you have any questions or need assistance, please do not hesitate to contact us at eccmidabstracts[at]escmid.org.